其中一种药物是抗炎药伐地考昔(Bextra)，在发现它可以增加心脏病和中风的危险性之后，辉瑞公司于2005年将其撤市。
One of those drugs was the anti-inflammatory medication Bextra, which Pfizer pulled off the market in 2005 after it was linked to increasing the risk of heart attacks and strokes.
其中一种药物是抗炎药伐地考昔(Bextra)，在发现它可以增加心脏病和中风的危险性之后，辉瑞公司于2005年将其撤市。
One of those drugs was the anti-inflammatory medication Bextra, which Pfizer pulled off the market in 2005 after it was linked to increasing the risk of heart attacks and strokes.
应用推荐